Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-183938
Filing Date
2021-06-07
Accepted
2021-06-07 11:02:58
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 12990
2 GRAPHIC g168165g87j57.jpg GRAPHIC 2653
  Complete submission text file 0001193125-21-183938.txt   17721
Mailing Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 301 SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations